Page 2242 - Williams Hematology ( PDFDrive )
P. 2242

2216  Part XII:  Hemostasis and Thrombosis            Chapter 129:  Disseminated Intravascular Coagulation           2217




                    183. Sack GH Jr, Levin J, Bell WR: Trousseau’s syndrome and other manifestations of chronic     218. Attar S, Boyd D, Layne E, et al: Alterations in coagulation and fibrinolytic mechanisms
                     disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and   in acute trauma. J Trauma 9:939, 1969.
                     therapeutic features. Medicine (Baltimore) 56:1, 1977.    219. Cosgriff N, Moore EE, Sauaia A, et al: Predicting life-threatening coagulopathy in the
                    184. Sallah S, Wan JY, Nguyen NP, et al: Disseminated intravascular coagulation in solid   massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma
                     tumors: Clinical and pathological study. Thromb Haemost 86:828, 2001.  42:857, 1997.
                    185. Donati MB: Cancer and thrombosis: From Phlegmasia alba dolens to transgenic mice.     220. Hess JR, Holcomb JB: Transfusion practice in military trauma. Transfus Med 18:143,
                     Thromb Haemost 74:278, 1995.                          2008.
                    186. Levi M: Cancer and thrombosis. Clin Adv Hematol Oncol 1:668, 2003.    221. Armand R, Hess JR: Treating coagulopathy in trauma patients.  Transfus Med Rev
                    187. Contrino J, Hair G, Kreutzer DL, et al: In situ detection of tissue factor in vascular   17:223, 2003.
                     endothelial cells: Correlation with the malignant phenotype of human breast disease.     222. Simmons RL, Collins JA, Heisterkamp CA, et al: Coagulation disorders in combat casu-
                     Nat Med 2:209, 1996.                                  alties. I: Acute changes after wounding. II: Effects of massive transfusion. 3. Post-resus-
                    188. Rickles FR, Brenner B: Tissue factor and cancer. Semin Thromb Hemost 34:143, 2008.  citative changes. Ann Surg 169:455, 1969.
                    189. Bromberg ME, Konigsberg WH, Madison JF, et al: Tissue factor promotes melanoma     223. Gomez R, Murray CK, Hospenthal DR, et al: Causes of mortality by autopsy findings of
                     metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A   combat casualties and civilian patients admitted to a burn unit. J Am Coll Surg 208:348,
                     92:8205, 1995.                                        2009.
                    190. Zhang Y, Deng Y, Luther T, et al: Tissue factor controls the balance of angiogenic and     224. Niles SE, McLaughlin DF, Perkins JG, et al: Increased mortality associated with the
                     antiangiogenic properties of tumor cells in mice. J Clin Invest 94:1320, 1994.  early coagulopathy of trauma in combat casualties. J Trauma 64:1459, 2008.
                    191. Nadir Y, Vlodavsky I, Brenner B: Heparanase, tissue factor, and cancer. Semin Thromb     225. Kaufman HH, Hui KS, Mattson JC, et al: Clinicopathological correlations of dissemi-
                     Hemost 34:187, 2008.                                  nated intravascular coagulation in patients with head injury. Neurosurgery 15:34, 1984.
                    192. Falanga A, Consonni R, Marchetti M, et al: Cancer procoagulant and tissue factor are     226. Stein SC, Chen XH, Sinson GP, et al: Intravascular coagulation: A major secondary
                     differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.   insult in nonfatal traumatic brain injury. J Neurosurg 97:1373, 2002.
                     Blood 92:143, 1998.                                  227. Olson JD, Kaufman HH, Moake J, et al: The incidence and significance of hemostatic
                    193. Levi M: Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin   abnormalities in patients with head injuries. Neurosurgery 24:825, 1989.
                     Haematol 22:129, 2009.                               228. Selladurai BM, Vickneswaran M, Duraisamy S, et al: Coagulopathy in acute head inju-
                    194. Wahrenbrock M, Borsig L, Le Duc M: Selectin-mucin interactions as a probable molec-  ry—A study of its role as a prognostic indicator. Br J Neurosurg 11:398, 1997.
                     ular explanation for the association of Trousseau syndrome with mucinous adenocarci-    229. Levi M: Burning issues surrounding inflammation and coagulation in heatstroke. Crit
                     noma. J Clin Invest 112:853, 2003.                    Care Med 36:2455, 2008.
                    195. Dvorak HF, Quay SC, Orenstein NS: Tumor shedding and coagulation. Science 212:923,     230. Garcia-Avello A, Lorente JA, Cesar-Perez J, et al: Degree of hypercoagulability and
                     1981.                                                 hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb
                    196. Zwicker JI: Tissue factor-bearing microparticles and cancer.  Semin Thromb Hemost   Res 89:59, 1998.
                     34:195, 2008.                                        231. Simon TL, Curreri PW, Harker LA: Kinetic characterization of hemostasis in thermal
                    197. Nijziel MR, van OR, Hillen HF, et al: From Trousseau to angiogenesis: The link between   injury. J Lab Clin Med 89:702, 1977.
                     the haemostatic system and cancer. Neth J Med 64:403, 2006.    232. Winkelman MD, Galloway PG: Central nervous system complications of thermal
                    198. Rickles FR, Falanga A: Molecular basis for the relationship between thrombosis and   burns. A postmortem study of 139 patients. Medicine (Baltimore) 71:271, 1992.
                     cancer. Thromb Res 102:V215, 2001.                   233. Carr ME Jr: Disseminated intravascular coagulation: Pathogenesis, diagnosis, and ther-
                    199. Stouthard JM, Levi M, Hack CE, et al: Interleukin-6 stimulates coagulation, not   apy. J Emerg Med 5:311, 1987.
                     fibrinolysis, in humans. Thromb Haemost 76:738, 1996.    234. Tytgat GN, Collen D, Verstraete M: Metabolism of fibrinogen in cirrhosis of the liver. J
                    200. van der Poll T, Coyle SM, Levi M, et al: Effect of a recombinant dimeric tumor necro-  Clin Invest 50:169, 1971.
                     sis factor receptor on  inflammatory responses to intravenous endotoxin in normal     235. Coleman M, Finlayson N, Bettigole RE, et al: Fibrinogen survival in cirrhosis: Improve-
                     humans. Blood 89:3727, 1997.                          ment by “low dose” heparin. Ann Intern Med 83:79, 1975.
                    201. van der Poll T, Levi M, ten Cate H, et al: The role of tumor necrosis factor in systemic     236. Coccheri S, Mannucci PM, Palareti G, et al: Significance of plasma fibrinopeptide A and
                     inflammatory responses in primate endotoxemia. Prog Clin Biol Res 388:425, 1994.  high molecular weight fibrinogen in patients with liver cirrhosis. Br J Haematol 52:503,
                    202. van der Poll T, Levi M, van Deventer SJ, et al: Differential effects of anti-tumor necro-  1982.
                     sis factor monoclonal antibodies on systemic inflammatory responses in experimental     237. Oka K, Tanaka K: Intravascular coagulation in autopsy cases with liver diseases. Thromb
                     endotoxemia in chimpanzees. Blood 83:446, 1994.       Haemost 42:564, 1979.
                    203. Sewnath ME, Olszyna DP, Birjmohun R, et al: IL-10-deficient mice demonstrate multi-    238. Paramo JA, Rifon J, Fernandez J, et al: Thrombin activation and increased fibrinolysis in
                     ple organ failure and increased mortality during Escherichia coli peritonitis despite an   patients with chronic liver disease. Blood Coagul Fibrinolysis 2:227, 1991.
                     accelerated bacterial clearance. J Immunol 166:6323, 2001.    239. Palascak JE, Martinez J: Dysfibrinogenemia associated with liver disease. J Clin Invest
                    204. van der Poll T, Jansen J, Levi M, et al: Interleukin 10 release during endotoxaemia in   60:89, 1977.
                     chimpanzees: Role of platelet-activating factor and interleukin 6.  Scand J Immunol     240. Ben-Ari Z, Osman E, Hutton RA, et al: Disseminated intravascular coagulation in liver
                     43:122, 1996.                                         cirrhosis: Fact or fiction? [See comments.] Am J Gastroenterol 94:2977, 1999.
                    205. van der Poll T, Jansen PM, Montegut WJ, et al: Effects of IL-10 on systemic inflamma-    241. Hollestelle MJ, Geertzen HG, Straatsburg IH, et al: Factor VIII expression in liver dis-
                     tory responses during sublethal primate endotoxemia. J Immunol 158:1971, 1997.  ease. Thromb Haemost 91:267, 2004.
                    206. Seligsohn U, Weber H, Yoran C: Microangiopathic hemolytic anemia and defibrination     242. Straub PW: Diffuse intravascular coagulation in liver disease? Semin Thromb Hemost
                     syndrome in metastatic carcinoma of the stomach. Isr J Med Sci 4:69, 1968.  4:29, 1977.
                    207. Uchiumi H, Matsushima T, Yamane A, et al: Prevalence and clinical characteristics of     243. Canoso RT, Hutton RA, Deykin D: The hemostatic defect of chronic liver disease.
                     acute myeloid leukemia associated with disseminated intravascular coagulation. Int J   Kinetic studies using  Se-selenomethionine. Gastroenterology 76:540, 1979.
                                                                                       75
                     Hematol 86:137, 2007.                                244. Tempero MA, Davis RB, Reed E, et al: Thrombocytopenia and laboratory evidence of
                    208. Barbui T, Falanga A: Disseminated intravascular coagulation in acute leukemia. Semin   disseminated intravascular coagulation after shunts for ascites in malignant disease.
                     Thromb Hemost 27:593, 2001.                           Cancer 55:2718, 1985.
                    209. Sarris AH, Kempin S, Berman E, et al: High incidence of disseminated intravascular     245. Bakker CM, Knot EA, Stibbe J, et al: Disseminated intravascular coagulation in liver
                     coagulation during remission induction of adult patients with acute lymphoblastic leu-  cirrhosis. J Hepatol 15:330, 1992.
                     kemia. Blood 79:1305, 1992.                          246. Wakefield EG, Hall WW: Heat injuries: A preparatory study for experimental heat-
                    210. Avvisati G, ten Cate JW, Sturk A, et al: Acquired alpha-2-antiplasmin deficiency in   stroke. JAMA 89:92, 1927.
                     acute promyelocytic leukaemia. Br J Haematol 70:43, 1988.    247. Chao TC, Sinniah R, Pakiam JE: Acute heat stroke deaths. Pathology 13:145, 1981.
                    211. Falanga A: Mechanisms of hypercoagulation in malignancy and during chemotherapy.     248. Bouchama A, Knochel JP: Heat stroke. N Engl J Med 346:1978, 2002.
                     Haemostasis 28 Suppl 3:50, 1998.                     249. Bouchama A, Hammami MM, Haq A, et al: Evidence for endothelial cell activation/
                    212. Stein E, McMahon B, Kwaan H, et al: The coagulopathy of acute promyelocytic leu-  injury in heatstroke. Crit Care Med 24:1173, 1996.
                     kaemia revisited. Best Pract Res Clin Haematol 22:153, 2009.    250. Gauss P, Meyer KA: Heat stroke: Report of one hundred and fifty-eight cases from Cook
                    213. Barbui T, Finazzi G, Falanga A: The impact of all-trans-retinoic acid on the coagulopa-  County Hospital, Chicago. Am J Med Sci 154:554, 1917.
                     thy of acute promyelocytic leukemia. Blood 91:3093, 1998.    251. Huisse MG, Pease S, Hurtado-Nedelec M, et al: Leucocyte activation: The link between
                    214. Gando S, Nakanishi Y, Tedo I: Cytokines and plasminogen activator inhibitor-1 in   inflammation and coagulation during heatstroke. A study of patients during the 2003
                     posttrauma disseminated intravascular coagulation: Relationship to multiple organ   heat wave in Paris. Crit Care Med 36:2288, 2008.
                     dysfunction syndrome. Crit Care Med 23:1835, 1995.    252. Mustafa KY, Omer O, Khogali M, et al: Blood coagulation and fibrinolysis in heat
                    215. Gando S: Disseminated intravascular coagulation in trauma patients. Semin Thromb   stroke. Br J Haematol 61:517, 1985.
                     Hemost 27:585, 2001.                                 253. Seegers WH, Ouyang C: Snake venoms and blood coagulation, in Snake Venoms, edited
                    216. Gando S: Tissue factor in trauma and organ dysfunction. Semin Thromb Hemost 32:48,   by L Chen-Yuan L, p 684. Springer Verlag, Berlin, 1979.
                     2006.                                                254. Huang TF, Holt JC, Lukasiewicz H, et al: Trigramin. A low molecular weight peptide
                    217. Owings JT, Gosselin RC, Anderson JT, et al: Practical utility of the D-dimer assay for   inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-
                     excluding thromboembolism in severely injured trauma patients. J Trauma 51:425, 2001.  IIIa complex. J Biol Chem 262:16157, 1987.







          Kaushansky_chapter 129_p2199-2220.indd   2217                                                                 17/09/15   3:46 pm
   2237   2238   2239   2240   2241   2242   2243   2244   2245   2246   2247